Cargando…

Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas

Gene expression profiles of malignant tumors surgically removed from ovarian cancer patients pre-treated with chemotherapy (neo-adjuvant) prior to surgery group into two distinct clusters. One group clusters with carcinomas from patients not pre-treated with chemotherapy prior to surgery (C-L), whil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, Carlos S., Matyunina, Lilya, Dickerson, Erin B., Schubert, Nina, Bowen, Nathan J., Logani, Sanjay, Benigno, Benedict B., McDonald, John F.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1859837/ https://www.ncbi.nlm.nih.gov/pubmed/17505532 http://dx.doi.org/10.1371/journal.pone.0000441

Ejemplares similares

Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
por: Bowen, Nathan J, et al.
Publicado: (2009)

Identification of candidate methylation-responsive genes in ovarian cancer
por: Menendez, Laura, et al.
Publicado: (2007)

Evidence for the Complexity of MicroRNA-Mediated Regulation in Ovarian Cancer: A Systems Approach
por: Shahab, Shubin W., et al.
Publicado: (2011)

Molecular Profiling Predicts the Existence of Two Functionally Distinct Classes of Ovarian Cancer Stroma
por: Lili, Loukia N., et al.
Publicado: (2013)

Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors
por: Menendez, Laura, et al.
Publicado: (2008)

Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis
por: Lili, Loukia N, et al.
Publicado: (2013)

Evidence for the importance of post-transcriptional regulatory changes in ovarian cancer progression and the contribution of miRNAs
por: Zhang, Mengnan, et al.
Publicado: (2017)

Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression
por: Hill, Christopher G, et al.
Publicado: (2014)

Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
por: Scharer, Christopher D, et al.
Publicado: (2008)

LTR retrotransposons and the evolution of dosage compensation in Drosophila
por: Matyunina, Lilya V, et al.
Publicado: (2008)

Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy
por: Huang, Cai, et al.
Publicado: (2018)

Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
por: Liu, Ying, et al.
Publicado: (2010)

Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity
por: Mezencev, Roman, et al.
Publicado: (2016)

The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated
por: Shahab, Shubin W, et al.
Publicado: (2012)

Functional and Evolutionary Significance of Human MicroRNA Seed Region Mutations
por: Hill, Christopher G., et al.
Publicado: (2014)

L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
por: Menendez, Laura, et al.
Publicado: (2004)

Evidence for the Importance of Personalized Molecular Profiling in Pancreatic Cancer
por: Lili, Loukia N., et al.
Publicado: (2014)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Conditional inactivation of PDCD2 induces p53 activation and cell cycle arrest
por: Granier, Celine J., et al.
Publicado: (2014)

LIMK2 Mediates Resistance to Chemotherapeutic Drugs in Neuroblastoma Cells through Regulation of Drug-Induced Cell Cycle Arrest
por: Gamell, Cristina, et al.
Publicado: (2013)

Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer
por: Merino, Vanessa F., et al.
Publicado: (2018)

Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis
por: Pan, Da, et al.
Publicado: (2013)

Rotational positioning of nucleosomes facilitates selective binding of p53 to response elements associated with cell cycle arrest
por: Cui, Feng, et al.
Publicado: (2014)

The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts
por: Tourell, Monique C., et al.
Publicado: (2017)

Absence of p53 in Clara cells favours multinucleation and loss of cell cycle arrest
por: Armit, Christopher J, et al.
Publicado: (2002)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Orostachys japonicus induce p53‐dependent cell cycle arrest through the MAPK signaling pathway in OVCAR‐3 human ovarian cancer cells
por: Lee, Kyung‐Sun, et al.
Publicado: (2018)

Gene expression profiling of epithelial ovarian tumours correlated with malignant potential
por: Warrenfeltz, Susanne, et al.
Publicado: (2004)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs
por: Singh, Rajendra K, et al.
Publicado: (2009)

Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest
por: Lützkendorf, Jana, et al.
Publicado: (2017)

Sophisticated Framework between Cell Cycle Arrest and Apoptosis Induction Based on p53 Dynamics
por: Hamada, Hiroyuki, et al.
Publicado: (2009)

Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53
por: Li, Frank Q., et al.
Publicado: (2007)

A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
por: Afjei, Rayhaneh, et al.
Publicado: (2022)

Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
por: Yang, Chen, et al.
Publicado: (2019)

Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
por: Kosowska, Agnieszka, et al.
Publicado: (2020)

p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs.
por: Malcomson, R. D., et al.
Publicado: (1995)

Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells
por: Mern, D S, et al.
Publicado: (2010)

53BP1 and USP28 mediate p53-dependent cell cycle arrest in response to centrosome loss and prolonged mitosis
por: Fong, Chii Shyang, et al.
Publicado: (2016)

Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression
por: Budhram-Mahadeo, Vishwanie S., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_fdg0spmfrgavvmhshbtqffgkgv